“The right blend”: $1 billion medicinal cannabis industry set to boom in South Australia
Friday, November 30, 2018/
Leaders from the medicinal cannabis industry met in Adelaide this week to discuss the future of the drug in Australia.
The Future of Medicinal Cannabis symposium, organised by medicinal cannabis producer LeafCann Group, featured national and global speakers discussing the challenges and opportunities of the emerging industry.
LeafCann founder and chief executive Elisabetta Faenza said South Australia could be a world leader in the sector, which was estimated to be worth US$7.7 billion in 2016 by market research firm Brightfield Group.
“Being able to lead in the production and the development of medicinal cannabis is somewhere that South Australia can really shine,” she said.
“Our vision is to establish South Australia as the centre of excellence for education, research, industry innovation and development for the global cannabis sector.”
Australia currently relies on imported medicinal cannabis products to meet patient demands.
“We expect the Australian medicinal cannabis market to be worth more than $1 billion by 2025,” Faenza said.
One of the challenges addressed at the conference was the need for more clinical trials on the symptomatic benefits of cannabis-based medicines.
Faenza said the advanced medical research facilities in South Australia provide excellent opportunities in this area.
“The ability of places like the South Australian Health and Medical Research Institute (SAHMRI) to have collaborative research is a big advantage, this means that Adelaide could really take a lead not only in Australia but globally in the development of cannabis-based medicines,” she said.
South Australian Minister for Industry and Skills David Pisoni, a keynote speaker at the conference, said the business opportunities for medicinal cannabis extend far beyond cultivation.
“It’s not just about growing cannabis, but more about South Australia being perfectly placed to engage in the sophisticated production, processing, manufacturing and commercialisation of a pharmaceutical-grade product,” he said.
“Our state has the right blend of strengths in advanced horticulture, research and specialised manufacturing to have a real competitive advantage in this space.”
Legislation that permits the legal cultivation of cannabis for medicinal purposes was passed in Australia in February 2016.
Pisoni said South Australia should have access to an optimal range of treatments and services to promote the best health outcomes for patients and the community.
“There is significant public interest and support for the medicinal use of cannabis and cannabis-derived products arising from reports of symptomatic benefit in a range of medical conditions,” he said.
“The state government supports the development of this industry within the existing Commonwealth regulatory framework and licencing regime.”
Access to cannabis-based medicines in Australia remains limited, with medical prescriptions involving a lengthy application process to obtain Commonwealth and relevant state approvals.
The South Australian government launched a simplified online application for medical professionals in April last year, aimed at streamlining the approval process for drug prescription.
LeafCann Group has launched its subsidiary Alchemy Bioservices to oversee the training and management of the emerging medicinal cannabis workforce in Australia.
A cultural war: What Hayne's report means for fintechs, accountants and small-business lending Charlotte Petris Timelio founder
In a perfect world: Canva's Melanie Perkins dreams about the future of Australian startups Melanie Perkins Canva co-founder
Swipe right for (data) validation: What dating apps can teach us about data security Leah Callon-Butler intimate.io co-founder
How do Australian startups tap into the $140 billion of dry powder sitting in the US? Andrea Kowalski Bailador partner
No silver bullet: Four steps to find the perfect sales and marketing channel for your startup Vinne Schifferstein Vidal Botown founder
Buzinga to Appster: An insider's theory on why the app giants keep falling Joseph Russell DreamWalk Apps co-founder
Got brand goals? The four most marketable sports of 2019 Andrew Montesi Pickstar head of marketing
What founders can do now to prepare for a possible 2019 recession Les Szekely EVP co-founder